Cargando…

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

Detalles Bibliográficos
Autores principales:	Hoepner, Robert, Kamm, Christian P, Friedli, Christoph, Salmen, Anke, Chan, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062573/ https://www.ncbi.nlm.nih.gov/pubmed/35411701 http://dx.doi.org/10.1111/cns.13841

Ejemplares similares

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022)

Modeling MOG Antibody–Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations
por: Remlinger, Jana, et al.
Publicado: (2023)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
por: Pistor, Maximilian, et al.
Publicado: (2022)

B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Cho, Eun Bin, et al.
Publicado: (2023)

B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
por: Levy, Michael, et al.
Publicado: (2021)

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Chen, Hai, et al.
Publicado: (2016)

Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020)

Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
por: Hyun, Jae-Won, et al.
Publicado: (2020)

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Arslan, Burak, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Spectrum of sublytic astrocytopathy in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2021)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
por: Briner, Myriam, et al.
Publicado: (2019)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study
por: Chaloulos-Iakovidis, Panagiotis, et al.
Publicado: (2021)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021)

Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica
por: Uzawa, Akiyuki, et al.
Publicado: (2010)

Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea
por: Kim, HyoJeong, et al.
Publicado: (2019)

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
por: Masuda, Hiroki, et al.
Publicado: (2020)

Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Sun, Jie, et al.
Publicado: (2023)

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
por: Jagtap, Sujit Abajirao, et al.
Publicado: (2015)

Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019)

Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
por: Deeb, Khaled, et al.
Publicado: (2019)

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy
por: Rebsamen, Michael, et al.
Publicado: (2022)

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2012)

Sleep abnormality in neuromyelitis optica spectrum disorder
por: Song, Yijun, et al.
Publicado: (2015)

Three cases of neuromyelitis optica spectrum disorder
por: Matsusue, Eiji, et al.
Publicado: (2016)

Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis
por: Seok, Hung Youl, et al.
Publicado: (2018)

Optic Perineuritis in Neuromyelitis Optica Spectrum Disorder
por: Kamaluddin, Nur Afiah, et al.
Publicado: (2019)

Differential diagnosis of neuromyelitis optica spectrum disorders
por: Kim, Sung-Min, et al.
Publicado: (2017)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Late Onset of Neuromyelitis Optica Spectrum Disorders
por: Fragoso, Yara Dadalti, et al.
Publicado: (2019)

Editorial: Advances in neuromyelitis optica spectrum disorders
por: Cai, Yu, et al.
Publicado: (2022)

Double-negative neuromyelitis optica spectrum disorder
por: Wu, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1g8oqv833bkegkp67j0vchq5pd